我要向钱看
liked
我要向钱看
liked
$Immutep(IMMP.US$
Immutep Announces Successful Meeting With FDA On Phase III Design In Non-Small Cell Lung Cancer; TACTI-004 Registrational Trial Will Enrol ~750 Patients Regardless Of PD-L1 Expression In Order To Address The Entire 1l NSCLC Market Eligible For Anti-PD-1 Therapy
Final discussion with the FDA, successfully concluding the regulatory preparations for the TACTI-004 Phase III trial design to evaluate efti in combination with KEYTRUDA (pembrolizumab), MSD's anti-PD-1 therapy, and sta...
Immutep Announces Successful Meeting With FDA On Phase III Design In Non-Small Cell Lung Cancer; TACTI-004 Registrational Trial Will Enrol ~750 Patients Regardless Of PD-L1 Expression In Order To Address The Entire 1l NSCLC Market Eligible For Anti-PD-1 Therapy
Final discussion with the FDA, successfully concluding the regulatory preparations for the TACTI-004 Phase III trial design to evaluate efti in combination with KEYTRUDA (pembrolizumab), MSD's anti-PD-1 therapy, and sta...
2
我要向钱看
liked
![Picture](https://sgsnsimg.moomoo.com/sns_client_feed/104324365/20240722/0b6d4d98e7566f4cd5176d0ae102c47a.jpg/thumb?area=104&is_public=true)
3
2
我要向钱看
liked
$Maxeon Solar Technologies(MAXN.US$ well good luck if you’re in this.The catalyst must have good news otherwise no price movement?
![Picture](https://sgsnsimg.moomoo.com/sns_client_feed/104324365/20240722/8dd7db77c94410768aefed8e8b7cc5df.jpg/thumb?area=104&is_public=true)
3
我要向钱看
liked
$Serve Robotics(SERV.US$ looks like we on good trend. Take note the info as of 21st July. i will update again 30min before premarket
![Picture](https://sgsnsimg.moomoo.com/sns_client_feed/104324365/20240722/7ef6c70aa583fe6d37f19d114314f528.jpg/thumb?area=104&is_public=true)
2